外体网络中的长非编码RNA:癌症癌症中的双重作用和临床影响
Goeun Yoon1, Seulhye Cho1, Yu-Ri Choi1
1Department of Science Education, Korea National University of Education, Cheongju-si, Chungbuk, 28173, Republic of Korea.
Animal cells and systems
|February 25, 2026
概括
外基因组携带长非编码RNA (lncRNAs),驱动癌症的发展和耐药性. 针对这些外体 lncRNAs 提供了改善癌症患者治疗结果的潜在治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 分子瘤学分子瘤学
- 生物化学 生物化学
背景情况:
- 外体是细胞外囊泡,通过转移生物活性分子来调解细胞间的通信.
- 长非编码RNAs (lncRNAs) 是包装在外体中的关键分子,影响受体细胞功能.
- 外体lncRNAs在癌症的发展,进展和治疗耐药性方面发挥着关键作用.
研究的目的:
- 审查外体长非编码RNAs (lncRNAs) 在癌症中的多方面的作用.
- 探索它们在瘤形成,瘤微环境和药物耐药性的参与.
- 突出其作为诊断生物标志物和治疗点的潜力.
主要方法:
- 在癌症中对外体 lncRNAs 的研究的文献综述.
- 对 lncRNAs 在表观遗传上调节基因表达的机制的分析.
- 对外体lncRNAs对瘤微环境和转移的影响的研究.
主要成果:
- 外体lncRNAs通过miRNA海绵,蛋白相互作用和甲基化来调节基因表达.
- 这些lncRNAs影响巨细胞的两极分化,免疫逃避,血管生成和转移.
- 外体 lncRNAs 在血清中可检测,作为液体活检的潜在生物标志物.
- 它们有助于各种癌症类型的耐药性.
结论:
- 外体lncRNAs是癌症发展和进展的重要驱动因素.
- 它们代表了通过液体活检进行早期诊断和监测的有希望的生物标志物.
- 向外体 lncRNAs 是一种可行的治疗策略,可以提高癌症治疗结果.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
02:39lncRNA - Long Non-coding RNAs
3.7K
3.7K
01:36Overview of Exosomes
3.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K
01:22MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
01:22MicroRNAs
24.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
01:32RNA Splicing
60.9K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.9K